GNRH1 and triple-negative breast carcinoma: LHRH has been recognized for its role in the negative autocrine/paracrine regulatory mechanism of cell proliferation, with expression in various malignant tumors, including endometrial, ovarian, and triple-negative breast cancers (TNBC) [20,21,22].